Scientific News Boston Scientific Q3 Earnings Preview
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Q3 Earnings Preview is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific: Q3 Earnings Snapshot
Boston Scientific Corp. (BSX) on Wednesday reported third-quarter profit of $755 million. On a per-share basis, the ... Read More
Boston Scientific rises as cardiology sales drive Q3 beat, guidance boost
Boston Scientific (BSX) stock rises as the company beats Q3 forecasts and raises full-year outlook thanks to strong cardiology sales. Read more here. Read More
Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings
Medical device company Boston Scientific (NYSE:BSX) will be announcing earnings results this Wednesday morning. Here’s what to expect. Boston Scientific beat analysts’ revenue expectations by 3.4% ... Read More
Boston Scientific sales grow more than 20% in Street-beating Q3
Boston Scientific (NYSE: BSX) shares ticked up before hours today on third-quarter results that came in ahead of the consensus forecast. Read More
Boston Scientific Delivers Robust Q3 Despite Tariff Headwinds: Analyst
Boston Scientific posts $5.07 billion in Q3 revenue, beats earnings estimates, sees WATCHMAN growth at 35%, and raises 2025 sales forecast. Read More
Acquisitive Boston Scientific sees growth rate ease in Q3
Boston Scientific’s third-quarter revenue topped $5 billion, up 20.3% year over year. Growth eased slightly from the second quarter, when sales rose more than 22%. Urology led the gains, up 28% year ... Read More
Boston Scientific Reports Strong Q3 2025 Results, Raises Full-Year Outlook
Boston Scientific reported Q3 2025 net sales of $5.07 billion and adjusted EPS of $0.75, topping expectations and supporting its upbeat full-year guidance. Read More
Boston Scientific (BSX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Boston Scientific (BSX) reported $5.07 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 20.3%. EPS of $0.75 for the same period compares to $0.63 a ... Read More
These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings
Morgan Stanley analyst Patrick Wood maintained Boston Scientific with an Overweight rating and raised the price target from $125 to $130. Wells Fargo analyst Larry Biegelsen maintained the stock with ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus